1. Chinese Pharmacopoeia Commission (2010) The pharmacopoeia of the People’s Republic of China, vol. 1. Chemical Industry Press, Beijing, pp 141, 260
2. Davis SM, Broderick J, Hennerici M et al (2006) Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology 66(8):1175–1181
3. Fan Y, Jin MW (2000) The influence of Liangxuetongyu oral solution on early rehabilitation of hypertensive cerebral hemorrhage. Chin J Integr Tradit West Med. 20:138–140 (Chinese)
4. Guo J, He Y, Chen S (2005) Clinical study on the therapeutic time window of acute intracerebral hemorrhage treated with herbal composition of Zhongfengxingnao taken orally. Chin J cerebrovasc Dis 2(6):255–259
5. He D, Liu QR, Zhao JX (2002) Therapeutic efficacy of Xueshuantong injection on patients with acute intracerebral hemorrhage in early stage. Chin J Integr Tradit West Med Intensive Crit Care 9:27–29 (Chinese)